Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · IEX Real-Time Price · USD

3.000

+0.090 (3.09%)

At close: Jul 26, 2024, 4:00 PM

2.898

-0.102 (-3.40%)

After-hours: Jul 26, 2024, 6:58 PM EDT

Allogene Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Revenue	0.09	0.1	0.16	114.09	-	-	Upgrade
Revenue Growth (YoY)	-30.40%	-39.10%	-99.86%	-	-	-	Upgrade
Cost of Revenue	214.94	242.91	256.39	220.18	192.99	144.54	Upgrade
Gross Profit	-214.85	-242.82	-256.23	-106.09	-192.99	-144.54	Upgrade
Selling, General & Admin	70.06	71.67	79.31	74.11	65.26	57.47	Upgrade
Operating Expenses	70.06	71.67	79.31	74.11	65.26	57.47	Upgrade
Operating Income	-284.9	-314.49	-335.54	-180.19	-258.24	-202.01	Upgrade
Interest & Investment Income	21.68	18.31	4.57	1.71	8.86	17.35	Upgrade
Earnings From Equity Investments	-8.67	-10.67	-12.88	-4.09	-67.31	-0.18	Upgrade
Other Non Operating Income (Expenses)	-0.16	-0.16	3.44	0.52	0.31	-0.09	Upgrade
EBT Excluding Unusual Items	-272.05	-307.02	-340.41	-182.05	-316.38	-184.93	Upgrade
Gain (Loss) on Sale of Investments	-7	-7	-	-	-	-	Upgrade
Asset Writedown	-13.25	-13.25	-	-	-	-	Upgrade
Pretax Income	-292.3	-327.27	-340.41	-182.05	-316.38	-184.93	Upgrade
Income Tax Expense	-	-	-	-	-	-0.33	Upgrade
Net Income	-292.3	-327.27	-340.41	-182.05	-316.38	-184.59	Upgrade
Net Income to Common	-292.3	-327.27	-340.41	-182.05	-316.38	-184.59	Upgrade
Shares Outstanding (Basic)	163	157	143	136	120	101	Upgrade
Shares Outstanding (Diluted)	163	157	143	136	120	101	Upgrade
Shares Change (YoY)	13.29%	9.63%	5.39%	12.84%	19.11%	249.11%	Upgrade
EPS (Basic)	-1.79	-2.09	-2.38	-1.34	-2.63	-1.83	Upgrade
EPS (Diluted)	-1.79	-2.09	-2.38	-1.34	-2.63	-1.83	Upgrade
Free Cash Flow	-227.48	-239.25	-225.71	-206.26	-181.05	-188.14	Upgrade
Free Cash Flow Per Share	-1.39	-1.52	-1.58	-1.52	-1.50	-1.86	Upgrade
Gross Margin	-	-	-	-92.99%	-	-	Upgrade
Operating Margin	-327475.86%	-331044.21%	-215087.18%	-157.94%	-	-	Upgrade
Profit Margin	-	-	-	-159.57%	-	-	Upgrade
Free Cash Flow Margin	-261473.56%	-251841.05%	-144685.90%	-180.79%	-	-	Upgrade
EBITDA	-270.66	-300.29	-321.24	-169.74	-250.81	-197.58	Upgrade
EBITDA Margin	-	-	-	-148.78%	-	-	Upgrade
D&A For EBITDA	14.25	14.2	14.3	10.45	7.44	4.42	Upgrade
EBIT	-284.9	-314.49	-335.54	-180.19	-258.24	-202.01	Upgrade
EBIT Margin	-	-	-	-157.94%	-	-	Upgrade

Source: S&P Capital IQ. Standard template.